Wuhan Huakang Century Clean Technology Co., Ltd. (SHE:301235)
34.53
-0.35 (-1.00%)
At close: Oct 19, 2026
SHE:301235 Revenue
Wuhan Huakang Century Clean Technology had revenue of 617.95M CNY in the quarter ending June 30, 2026, with 14.51% growth. This brings the company's total for the last twelve months to 2.47B, up 24.43% year-over-year. In the year 2025, Wuhan Huakang Century Clean Technology had annual revenue of 2.29B with 33.87% growth. That makes Wuhan Huakang Century Clean Technology the 13,060th largest company in the world by revenue and 2,272nd in China.
Revenue (ttm)
2.47B
Revenue Growth
+24.43%
P/S Ratio
1.90
Revenue / Employee
n/a
Employees
2,067
Market Cap
4.69B
Revenue by Segment
- Purification System Integration Business 2.02B 88.5%
- Medical Supplies Sales 145.63M 6.4%
- Medical Equipment Sales 67.43M 2.9%
- Operation and Maintenance Service 37.71M 1.6%
- Unallocated Other 12.52M 0.5%
Fiscal year ended Dec 31, 2025 See the full SHE:301235 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.29B | 578.41M | 33.87% |
| Dec 31, 2024 | 1.71B | 106.27M | 6.64% |
| Dec 31, 2023 | 1.60B | 412.66M | 34.71% |
| Jan 1, 2023 | 1.19B | 328.10M | 38.12% |
| Jan 1, 2022 | 860.81M | 98.99M | 12.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen YHLO Biotech | 1.89B |
| BMC Medical | 1.38B |
| Shenzhen Lifotronic Technology | 1.13B |
| Getein Biotech | 1.09B |
| SWS Hemodialysis Care | 913.38M |
| Xiangyu Medical Co.,Ltd | 781.87M |
| Shanghai Kinetic Medical | 777.21M |
| Hangzhou AGS MedTech | 592.88M |